Dr Neal Jain Discusses Type 2 Inflammation in Asthma
The majority of patients with asthma have type 2 inflammation, and the introduction of dupilumab has changed the treatment space for these patients, said Neal Jain, MD, FAAP, FAAAAI, director of research at Arizona Allergy & Immunology Research and a co-owner of Arcadia Allergy & Asthma and San Tan Allergy & Asthma.
Watch video Dr Neal Jain Discusses Type 2 Inflammation in Asthma online without registration, duration hours minute second in high quality. This video was added by user AJMCtv MJH 30 September 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,700 once and liked it 20 people.